Muhammed ali Kızmaz

Mr. Muhammed ali Kızmaz

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2022 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
ASAbdurrahman Simsek
Abdurrahman Simsek
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
ECEren Cagan
Eren Cagan
FDFatma Dombaz
Fatma Dombaz
Gulcin TezcanGulcin Tezcan
Gulcin Tezcan
FBFerah Budak
Ferah Budak
COVID‐19 is a disease characterized by acute respiratory failure and is a major health problem worldwide. Here, we aimed to investigate the role of CD39 expression in Treg cell subsets in COVID‐19 immunopathogenesis and its relationship to disease severity. One hundred and ninety COVID‐19 patients (juveniles, adults) and 43 volunteers as healthy controls were enrolled in our study. Flow cytometric analysis was performed using a 10‐color monoclonal antibody panel from peripheral blood samples. In adult patients, CD39+ Tregs increased with disease severity. In contrast, CD39+ Tregs were decreased in juvenile patients in an age‐dependent manner. Overall, our study reveals an interesting profile of CD39‐expressing Tregs in adult and juvenile cases of COVID‐19. Our results provide a better understanding of the possible role of Tregs in the mechanism of immune response in COVID‐19 cases.

16 January 2023 in Immunological Investigations
Verified
Journal Article
Closed access
PEPınar Hız Ellergezen
Pınar Hız Ellergezen
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
ASAbdurrahman Simsek
Abdurrahman Simsek
NDNesrin Demir
Nesrin Demir
ECEren Cagan
Eren Cagan
FBFerah Budak
Ferah Budak
Brucellosis is significantly influenced by the interactions between the causative Brucella bacteria and host immunity. Recently identified cytokines have been described for their immunomodulatory effects in numerous inflammatory, autoimmune and infectious diseases. Some of them are new members of cytokine superfamilies, including several members of the IL-12 superfamily (IL-35, IL-39). The major purpose of the present study was to investigate the role of these new immunomodulatory cytokines in Brucella infections. The levels of IL-35 and IL-39 in the serum of 40 acute and 40 chronic brucellosis patients and 40 healthy controls were measured by ELISA. The mRNA levels of IL-35 and IL-39 in PBMCs were detected by RT-qPCR. Both IL-35 and IL-39 serum concentrations were significantly higher in healthy control subjects than in brucellosis patients, and IL-35 and IL-39 serum levels of chronic brucellosis patients were higher than those of acute cases. It was also found that the expression of Ebi3/IL-12A (IL-35 genes) and Ebi3/IL-23A (IL-39 genes) was upregulated in chronic brucellosis patients compared to healthy controls. Moreover, the expression of the Ebi3/IL-12A and Ebi3/IL-23A genes was lower in patients with acute brucellosis than in patients with chronic brucellosis. Overall, this study showed that IL-35 and IL-39 are positively correlated in brucellosis and significantly decreased during the disease. Significantly lower levels of IL-35 and IL-39 in acute brucellosis than in chronic brucellosis and healthy controls suggest that these cytokines may play a key role in suppressing the immune response to brucellosis and its progression to chronicity.

22 September 2022 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
ASAbdurrahman Simsek
Abdurrahman Simsek
TBTugce Bozkurt
Tugce Bozkurt
ECEren Cagan
Eren Cagan
FDFatma Dombaz
Fatma Dombaz
FBFerah Budak
Ferah Budak

1 January 2024 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Open access
PDF file
AIAli Eren Işkın
Ali Eren Işkın
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
FBFerah Budak
Ferah Budak
Amaç: Bitkisel gıdalarda yaygın olarak bulunan ve kristalik bileşikler olarak da bilinen flavonoidler, optik aktivite özelliği gösteren bileşiklerdir. İskelet yapılarının farklılıklarına dayalı olarak alt tipleri bulunmaktadır. Luteolin (LUT), boyacı katırtırnağı (Genista tinctoria) ve muhabbet çiçeği (Reseda luteola) bitkilerinden elde edilen önemli bir flavondur. Yapılan çalışmalarda, anti-oksidan, anti-enflamatuvar, immünomodülatör, anti-kanser ve nöroprotektif gibi birçok özellik sergilediği bildirilmiştir. LUT gibi doğal ürünlerden elde edilen bileşiklerin, kanser, otoimmün, nörodejeneratif ve kronik hastalıkların gelişiminde önemli rolleri nedeniyle çok sayıda araştırmanın odak noktası haline gelmiştir. Bu derlemedeki amacımız, otoimmün hastalıklarda LUT bileşiğinin terapötik rolünü değerlendirmektir. Sonuç ve Tartışma: Çeşitli sebzelerde, meyvelerde bulunan ve değişken bir fenolik madde yapısına sahip olan LUT bileşiğinin; sistemik lupus eritematozus, romatoid artrit, astım, multipl skleroz, otoimmün ensefalit, ülseratif kolit, otoimmün diyabet, psoriasis, otoimmün tiroidit ve üveit gibi bazı otoimmün hastalıklarda anti-enflamatuvar, anti-oksidan, immünomodülatör ve nöroprotektif aktiviteler sergilediği bildirilmiştir. Ancak, LUT bileşiğinin toksisitesi ile ilgili endişe verici bazı bulgular da raporlanmaştır. Gelecekte yapılacak olan farmakokinetik, toksisite, kombine tedavi ve moleküler biyoloji çalışmaları LUT bileşiğinin sağlık üzerindeki etkilerini daha iyi anlamamıza yardımcı olabilir.

22 August 2024 in Children
Verified
Journal Article
Open access
PDF file
SÇSalih Çağrı Çakır
Salih Çağrı Çakır
BDBayram Ali Dorum
Bayram Ali Dorum
HÖHilal Özkan
Hilal Özkan
NKNilgün Köksal
Nilgün Köksal
FKFatma Kocael
Fatma Kocael
KEKevser Üstün Elmas
Kevser Üstün Elmas
Background: The aim of this study is to investigate the diagnostic value of cerebrospinal fluid (CSF) and serum levels of the soluble form of triggering receptor-1 expressed on myeloid cells (sTREM-1) in neonatal meningitis. Methods: Serum sTREM-1 levels were measured in all neonatal sepsis patients at the start of antibiotic therapy and the 48th hour of treatment. At the beginning of antibiotic therapy, CSF samples were collected for sTREM-1 measurements. Control CSF samples were also collected from the patients with meningitis at the 48th hour of treatment. Results: A total of 77 preterm (50) and term (27) patients with neonatal sepsis were included in the study. There was no significant difference between the CSF sTREM-1 levels of patients with and without meningitis. The CSF sTREM-1 levels of preterm infants with meningitis decreased significantly after treatment (p = 0.038). Although the CSF/serum sTREM-1 ratios tended to increase in babies with meningitis, no significant difference was found between the groups. CSF/serum sTREM-1 ratios (mean ± SD) were 1.42 ± 0.91 and 1.14 ± 0.85 in preterm babies with and without meningitis and 1.15 ± 0.97 and 0.97 ± 0.55 in term babies with and without meningitis, respectively. Conclusions: Serum and CSF sTREM-1 levels increase in patients with neonatal sepsis. CSF s-TREM-1 levels decrease after treatment in preterm infants with meningitis.

29 December 2023 in Current HIV Research
Verified
Journal Article
Closed access
PDF file
MKMuhammed ali Kızmaz
Muhammed ali Kızmaz
ASAbdurrahman Simsek
Abdurrahman Simsek
FAFigen Aymak
Figen Aymak
EAEMİN HALİS Akalin
EMİN HALİS Akalin
HOHaluk Barbaros Oral
Haluk Barbaros Oral
FBFerah Budak
Ferah Budak
Objectives: The aim of our study is to reveal the prevalence of HLA-B*57 in the Turkish population and to provide new perspectives to physicians starting abacavir therapy in HIV patients. Background: Abacavir, one of the drugs used to treat HIV infection, can cause hypersensitivity reactions in some patients. These hypersensitivity reactions have been shown to be associated with the HLA-B*57:01 allele. High-resolution HLA-B*57:01 scanning has a time and cost disadvantage compared with low-resolution HLA-B*57 scanning. Before starting abacavir treatment, we will discuss whether high-resolution scanning is more beneficial in individuals who are positive on HLA-B*57 screening. This is the study with the largest cohort to investigate the prevalence of HLA-B*57 in Turkey. Methods: The results of 25 thousand 318 people who applied to Bursa Uludağ University Faculty of Medicine, Department of Immunology for HLA-B* typing were scanned. Results: In our study, the HLA-B*57 serotype was detected in 827 (3.3%) individuals. Conclusion: Considering these results, it can be assumed that the prevalence of HLA-B*57:01 in Turkey is lower than 3.3%. Instead of a high-resolution HLA-B*57:01 scan in all patients starting abacavir therapy, a high-resolution HLA-B*57:01 scan might be of greater benefit in patients who are positive on a low-resolution HLA-B*57 scan.